Early experience of stereotactic irradiation for acoustic tumors

M. Sato, M. Kitamura, E. Kunieda, A. Kubo, Takayuki Oohira, J. Kanzaki

Research output: Contribution to journalArticle

Abstract

We have treated ten patients with acoustic tumors by stereotactic radiosurgery (SRS). Out of ten patients, three had tumor regrowth 10 to 27 months after treatment. We suspect that relatively high regrowth rate comes from high incidence of post-operative residual tumors among the irradiated cases. We need to make efforts to decrease regrowth and side effects like facial nerve palsy. From 1997, we started stereotactic radiotherapy (SRT) that is expected to have advantage in radiation biology and no significant side effects have been experienced so far.

Original languageEnglish
Pages (from-to)1793-1797
Number of pages5
JournalJapanese Journal of Clinical Radiology
Volume43
Issue number13
Publication statusPublished - 1998

Fingerprint

Acoustic Neuroma
Radiobiology
Radiosurgery
Facial Paralysis
Facial Nerve
Residual Neoplasm
Radiotherapy
Incidence
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Sato, M., Kitamura, M., Kunieda, E., Kubo, A., Oohira, T., & Kanzaki, J. (1998). Early experience of stereotactic irradiation for acoustic tumors. Japanese Journal of Clinical Radiology, 43(13), 1793-1797.

Early experience of stereotactic irradiation for acoustic tumors. / Sato, M.; Kitamura, M.; Kunieda, E.; Kubo, A.; Oohira, Takayuki; Kanzaki, J.

In: Japanese Journal of Clinical Radiology, Vol. 43, No. 13, 1998, p. 1793-1797.

Research output: Contribution to journalArticle

Sato, M, Kitamura, M, Kunieda, E, Kubo, A, Oohira, T & Kanzaki, J 1998, 'Early experience of stereotactic irradiation for acoustic tumors', Japanese Journal of Clinical Radiology, vol. 43, no. 13, pp. 1793-1797.
Sato M, Kitamura M, Kunieda E, Kubo A, Oohira T, Kanzaki J. Early experience of stereotactic irradiation for acoustic tumors. Japanese Journal of Clinical Radiology. 1998;43(13):1793-1797.
Sato, M. ; Kitamura, M. ; Kunieda, E. ; Kubo, A. ; Oohira, Takayuki ; Kanzaki, J. / Early experience of stereotactic irradiation for acoustic tumors. In: Japanese Journal of Clinical Radiology. 1998 ; Vol. 43, No. 13. pp. 1793-1797.
@article{7adf612393c0428184bda447fca95a22,
title = "Early experience of stereotactic irradiation for acoustic tumors",
abstract = "We have treated ten patients with acoustic tumors by stereotactic radiosurgery (SRS). Out of ten patients, three had tumor regrowth 10 to 27 months after treatment. We suspect that relatively high regrowth rate comes from high incidence of post-operative residual tumors among the irradiated cases. We need to make efforts to decrease regrowth and side effects like facial nerve palsy. From 1997, we started stereotactic radiotherapy (SRT) that is expected to have advantage in radiation biology and no significant side effects have been experienced so far.",
author = "M. Sato and M. Kitamura and E. Kunieda and A. Kubo and Takayuki Oohira and J. Kanzaki",
year = "1998",
language = "English",
volume = "43",
pages = "1793--1797",
journal = "Japanese Journal of Clinical Radiology",
issn = "0009-9252",
publisher = "Kanehara Shuppan Co. Ltd",
number = "13",

}

TY - JOUR

T1 - Early experience of stereotactic irradiation for acoustic tumors

AU - Sato, M.

AU - Kitamura, M.

AU - Kunieda, E.

AU - Kubo, A.

AU - Oohira, Takayuki

AU - Kanzaki, J.

PY - 1998

Y1 - 1998

N2 - We have treated ten patients with acoustic tumors by stereotactic radiosurgery (SRS). Out of ten patients, three had tumor regrowth 10 to 27 months after treatment. We suspect that relatively high regrowth rate comes from high incidence of post-operative residual tumors among the irradiated cases. We need to make efforts to decrease regrowth and side effects like facial nerve palsy. From 1997, we started stereotactic radiotherapy (SRT) that is expected to have advantage in radiation biology and no significant side effects have been experienced so far.

AB - We have treated ten patients with acoustic tumors by stereotactic radiosurgery (SRS). Out of ten patients, three had tumor regrowth 10 to 27 months after treatment. We suspect that relatively high regrowth rate comes from high incidence of post-operative residual tumors among the irradiated cases. We need to make efforts to decrease regrowth and side effects like facial nerve palsy. From 1997, we started stereotactic radiotherapy (SRT) that is expected to have advantage in radiation biology and no significant side effects have been experienced so far.

UR - http://www.scopus.com/inward/record.url?scp=0032441198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032441198&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 1793

EP - 1797

JO - Japanese Journal of Clinical Radiology

JF - Japanese Journal of Clinical Radiology

SN - 0009-9252

IS - 13

ER -